Our previous study showed that treatment of highly invasive rat ascites hepatoma (LC-AH) cells with α α α α-difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase, decreased both their intracellular level of putrescine and their in vitro invasion of a monolayer of calf pulmonary arterial endothelial (CPAE) cells, and that both these decreases were completely reversed by exogenous putrescine, but not spermidine or spermine. Here we show that all adhering control (DFMOuntreated) cells migrated beneath CPAE monolayer with morphological change from round to cauliflower-shaped cells (migratory cells ] i by inhibiting endoplasmic Ca 2+ -ATPase, indicating that thapsigargin mimics the effects of putrescine. These results support the idea that putrescine is a cofactor for Ca 2+ release through the Ca 2+ channel in the endoplasmic reticulum that is inhibited by ryanodine, this release being initiated by cell adhesion and being a prerequisite for tumor cell invasion.
The polyamines spermidine and spermine, and the diamine putrescine, as well as normal constituents of all animal cells. On the basis of their metabolism under various physiological conditions as well as the effects of specific inhibitors of polyamine biosynthesis, polyamines have been suggested to be important in various cellular functions such as proliferation, differentiation, [1] [2] [3] [4] cytoskeleton construction, 5) membrane transport 6, 7) and receptor responses. 8, 9) However, their physiological roles are not yet well defined at the molecular level.
We previously reported that pretreatment of a highly invasive tumor cell line, LC-AH cells, with DFMO, a specific irreversible inhibitor of ornithine decarboxylase (EC 4.1.1.17), decreased both their intracellular level of putrescine and their invasion beneath a CPAE cell monolayer, without change in their viability, proliferative activity or levels of spermidine and spermine. 10) We also showed that these DFMO-induced decreases were completely reversed by putrescine added to the culture medium during pretreatment with DFMO or during invasion assay in which LC-AH cells were co-cultured with a CPAE cell layer for 24 h.
Moreover, these reverses were observed only with putrescine, not with 1,3-diaminopropane, spermidine or spermine. 10) The LC-AH cells used in these studies have a very high cellular putrescine level (73 nmol/mg DNA) which is similar to their spermidine level (70 nmol/mg DNA). 10) This high putrescine level is a characteristic of these highly invasive LC-AH cells, the putrescine levels in a variety of other tumor cells such as Ehrlich ascites, 11) B16 melanoma, 12) Lewis lung carcinoma, 13) and leukemia 14) cells being less than 30% of their spermidine levels. Pretreatment with 0.5 mM DFMO for 5 h induced a 64% decrease in their putrescine level without significant changes in their intracellular levels of spermidine and spermine. 10) Although 0.5 mM DFMO completely inhibited the ornithine decarboxylase activity of LC-AH cells for more than 24 h, the presence of 0.5 mM DFMO during invasion assay did not furhter reduce either their putrescine level or invasiveness, but significantly decreased their spermidine level (48 nmol/ mg DNA) without change in their spermine level (our unpublished data). This finding suggests formation of putrescine from spermidine through oxidation of acetylspermidine, as has been observed in a variety of animal tissues and cultured cells, 15) including isoproterenolstimulated mouse parotid gland, 16) calcitriol-activated chick duodenum, 17) rat brain, 18) and human melanoma cells. 19) In the former two in vivo studies, marked increases in tissue putrescine levels with concomitant decreases in spermidine levels were observed after injections of the hormones.
These high cellular levels of putrescine and back-conversion of spermidine to putrescine, which is followed by induction of ornithine decarboxylase, 16, 17) imply that putrescine is involved in cellular events besides being a precursor of spermidine. However, its exact function is unknown.
In this paper, we investigated the role of putrescine in the invasiveness of LC-AH cells, and showed that it participates in elevation of [Ca 2+ ] i through a ryanodine receptor located in the endoplasmic reticulum.
MATERIALS AND METHODS
Materials Indo 1-AM was purchased from Dojindo Laboratories (Kumamoto). Ionomycin, A23187, verapamil, nifedipine, diltiazem, ryanodine and thapsigargin were obtained from Wako Pure Chemical Industries (Osaka). The sources of other chemicals, and LC-AH and CPAE cells were as reported previously.
10)
Cell culture and assay of cell invasiveness These assays were done as reported previously. 10) Briefly, LC-AH and CPAE cells were cultured at 37°C in a CO 2 incubator in DMEM supplemented with NaHCO 3 , antibiotics and 10% (LC-AH cells) or 20% (CPAE cells) FCS. For treatment of LC-AH cells with DFMO, the cells (1.0×10 6 cells/ml) were cultured in 10% FCS-DMEM containing 0.5 mM DFMO for 5 h and then washed with fresh medium to remove DFMO. Volumes of 1 ml of LC-AH cell suspension (2×10 4 cells) were seeded onto confluent CPAE cell monolayers grown on 12-well plates (3.8 cm 2 ). After co-culture for 24 h (migration period) in the absence or presence of putrescine or test drugs, cells were fixed with 10% formalin, and the numbers of tumor cells that had penetrated the CPAE cell layers were counted under a phase-contrast microscope.
Assay of cell adhesiveness
The adhesion of the tumor cells to the CPAE cell layer was determined as follows. LC-AH cells (1×10 5 cells) suspended in 4 ml of 10% FCS-DMEM were seeded onto confluent CPAE cell layers in 60 mm dishes. After co-culture for 0.5-6 h, the culture medium was removed and the CPAE cell layers were gently washed with 4 ml of fresh DMEM. The numbers of nonadhered cells in the combined media were counted under a microscope and the CPAE cell layers were cultured further for 24 h in 4 ml of 10% FCS-DMEM to assay the invasiveness of LC-AH cells that had adhered to the CPAE cell layers. Cell adhesion was calculated by subtracting the number of nonadhered cells from the number of cells seeded (1×10 5 cells). Assay of cell membrane fluidity Membrane fluidity was assessed by fluorescence polarization as reported previously. 20 ] i in LC-AH cells that had penetrated the CPAE cell layer, indo 1-AM was loaded into the co-cultured cells 24 h after inoculation of LC-AH cells and the fluorescence intensity in the tumor cells was measured as described above.
The results in figures are shown as typical traces of results in at least three separate experiments. Polyamine determination DFMO-treated cells (1×10 6 cells) were suspended in 1 ml of 10% FCS-DMEM and cultured at 37°C for 0-20 min in the presence of 20 µM putrescine. Polyamines were measured as described previously.
10)
Statistical analysis Results were compared by Student's t test and a P value of 0.05 or less was regarded as significant.
RESULTS

Effects of DFMO and putrescine on membrane fluidity, adhesion and invasiveness of LC-AH cells
We found previously that the maximal DFMO-induced decreases in the putrescine level (36% of the control) and invasiveness (62% of the control) of LC-AH cells were observed when the cells had been pretreated with 0.5 mM DFMO for 5 h and then co-cultured with a CPAE cell monolayer for 24 h (migration period) in the absence of DFMO. These decreases were completely reversed by 20 µM putrescine added to the culture medium during pretreatment or the migration period. 10) We also showed that methylthioadenosine and its analogues suppressed the invasiveness of LC-AH cells and that this suppression was associated with reductions of both methylation of tumor membrane phospholipids and tumor membrane fluidity, measured by a steady-state fluorescence polarization method. 20) The process of in vitro invasion of LC-AH cells through a CPAE cell layer consists of two steps, adhesion of the tumor cells to the cell layer and their migration through it. Neither DFMO nor exogenous putrescine alone affected the membrane fluidity or the adhesiveness of LC-AH cells (Table I). Under the experimental conditions employed, about 35% of the inoculated cells adhered to a CPAE cell layer within 30 min after their inoculation, and this value increased to a maximum of 46% within 2 h after cell inoculation. No further increase was observed by 6 h after cell inoculation (data not shown). But this maximal ratio (46%) of adherent cells increased when a smaller number of LC-AH cells was inoculated onto the same-sized CPAE cell monolayer (unpublished data), suggesting a limited number of binding sites in the CPAE cell layer for tumor cells. In control (DFMO-untreated) and putrescine-treated cells which showed high putrescine levels, 10) all these adherent cells migrated through the CPAE cell layer (migratory cells) during the migration period. In DFMO-treated cells, however, 39% (0.5 h co-cultured cells) and 36% (2 h cocultured cells) of the adhered cells did not migrate (nonmigratory cells), but remained adhering to the CPAE cell layer after 24 h incubation (Table I) . These nonmigratory cells showed no migration even 30 h after inoculation. Addition of 20 µM putrescine to the medium during the migration period restored cell invasiveness and all of the nonmigratory cells began to penetrate the CPAE cell layer (Table I) . Thus, DFMO treatment induced nonmigratory cells, which were transformed to migratory cells in the presence of putrescine.
As shown in Fig. 1 ] i of DFMO-induced nonmigratory LC-AH cells after additions of polyamines. Fig. 2 shows that on addition of putrescine, the [Ca 2+ ] i of nonmigratory cells was increased to the same level as in migratory cells within 10 min, with complete recovery of their invasiveness (Table I) We could not measure the putrescine levels of DFMOtreated migratory cells after addition of putrescine because the adhered migratory cells were not easily detached from the CPAE cell layer. When DFMO-treated LC-AH cells were cultured at 37°C without the CPAE cell layer and polyamine levels were followed after addition of putrescine by the method described in "Materials and Methods," the putrescine levels (nmol/µg DNA, average values of two experiments) were 21.3 (0 min), 43.8 (5 min), 64.3 (10 min), and 80.1 (20 min), indicating that the level 10 min after addition of putrescine was almost the same as that of DFMOuntreated cells (70.5 nmol/µg DNA). No changes in spermidine and spermine levels were observed. These results suggested that uptake of exogenous putrescine was associated with increase of [ 23) and an inhibitor (thapsigargin) of endoplasmic reticulum Ca 2+ -ATPase. 24) These drugs were added to the culture medium during the migration period. Fig. 3 shows that none of the calcium ionophores (10 µM) or antagonists (20 µM) of the voltage-gated Ca 2+ channel affected the invasiveness of control cells, the DFMO-dependent suppression of invasion or the putrescine-dependent restoration of DFMO-induced suppression of the invasion. These calcium channel antagonists were reported to be effective in various tumor cells at concentrations of less than 20 µM. [25] [26] [27] [28] [29] On the other hand, ryanodine and thapsigargin, which modulate Ca 2+ release in the endoplasmic reticulum, had definite influences on the invasiveness. Ryanodine concentration-dependently low- (Fig. 4B ) and the invasiveness of the cells (Fig. 4A) , and the ryanodine-treated nonmigratory cells also had a low [Ca 2+ ] i (data not shown). In other words, the [Ca 2+ ] i remained low in all the nonmigratory cells induced by either DFMO or ryanodine. In contrast, thapsigargin alone dose-dependently enhanced the invasiveness of DFMO-treated cells (Fig. 4C ) with elevation of their [Ca 2+ ] i in the absence of putrescine (Fig. 4D ). But thapsigargin alone had no effect on the invasiveness of control cells (Fig. 3A) . These effects of thapsigargin were similar to those of putrescine. Ionomycin had no effect on the invasiveness (Fig. 3) , but increased the [Ca 2+ ] i . Fig. 5 shows the surge of increase in [Ca 2+ ] i in a DFMO-induced nonmigratory cell after addition of ionomycin to the medium during the migration period. This pattern of increase in [Ca 2+ ] i was markedly different from those induced by putrescine and thapsigargin (Fig. 4D) . The maximal [Ca 2+ ] i 1 min after addition of ionomycin was 3 times that 10 min after addition of putrescine or thapsigargin, but the ionomycin-induced increase lasted for only 2 min whereas the putrescine-and thapsigargin-induced increase persisted for at least the 10 min measurement period (Figs. 2, 4 and 5) . These results suggest that a prolonged increase in [Ca 2+ ] i is necessary for restoration of invasiveness after DFMO treatment. Nifedipine did not suppress the putrescine-evoked increase in [Ca 2+ ] i in nonmigratory cells (Fig. 5) .
DISCUSSION
The present studies by ACAS laser cytometry and microscopy showed that all control LC-AH cells that adhered to a CPAE cell layer showed an increase in [Ca 2+ ] i , followed by change from a round to a cauliflower-like shape (Fig. 1) , and then migration through the CPAE cell layer. After penetration through the CPAE cell layer, the cells again had a low [Ca 2+ ] i (Fig. 1) . We found no transformed cells (migratory cells) with a low [Ca 2+ ] i and no nonmigratory cells or cells that had penetrated the cell layer with a high [Ca 2+ ] i at any time after cell inoculation. These findings suggest that migratory cells maintain a high [Ca 2+ ] i during their migration period and that this level returns to the original low level after their invasion of the CPAE cell layer. In DFMO-induced nonmigratory cells, the [Ca 2+ ] i was rapidly elevated for a prolonged time to the level in migratory cells by addition of putrescine, but not spermidine or spermine (Fig. 2) . This implies that a high intracellular level of putrescine is necessary for the increase in [Ca 2+ ] i evoked by adhesion of the tumor cells to the CPAE cell layer and is prerequisite for their invasion of the layer. ] i and the invasiveness of the cells were concomitantly decreased and increased by ryanodine and thapsigargin, respectively (Figs. 3 and 4) .
The putrescine-dependent increase in [Ca 2+ ] i in DFMOtreated nonmigratory cells was probably due to release of Ca 2+ from the endoplasmic reticulum because this increase was not affected by nifedipine (Fig. 5 ) which inhibits influx of extracellular Ca 2+ into the cells, but was completely inhibited by ryanodine (Fig. 4B) , a blocker of the Ca 2+ -induced Ca 2+ -release system through the endoplasmic ryanodine receptor.
23) The possibility of participation of putrescine-dependent Ca 2+ release from the endoplasmic reticulum in induction of invasiveness was supported by the putrescine-like effects of thapsigargin (Figs. 3 and 4) , which is thought to restore the invasiveness of nonmigratory cells due to increase in their [Ca 2+ ] i by decrease in influx of cytoplasmic Ca 2+ into the endoplasmic reticulum through the inhibition of endoplasmic Ca 2+ -ATPase. 24) There are reports that cyclic ADP-ribose is a natural agonist of the ryanodine channel in a variety of animal cells [30] [31] [32] [33] [34] [35] and that this channel is independently regulated by other endoplasmic reticulum-located Ca 2+ -releasing systems that are triggered by inositol 1,4,5-trisphosphate, [33] [34] [35] and nicotinate adenine dinucleotide phosphate. [36] [37] [38] The complete inhibitions by ryanodine of putrescine-dependent recoveries of the [Ca 2+ ] i and invasiveness of nonmigratory cells suggest that putrescine is involved in either the increase in the cellular level of cyclic ADP-ribose which is initiated by the adhesion of LC-AH cells to a CPAE cell layer or the functional expression of this cyclic nucleotide. Bourguignon et al. 39) reported that binding of the ryanodine receptor to ankyrin, a cytoskeleton protein, evoked cyclic ADP-riboseinduced Ca 2+ release from internal vesicles of T-lymphoma cells. In connection with the functional expression, Chini et al. 40) reported that cyclic ADP-ribose-induced Ca 2+ release in a homogenate of sea urchin eggs was strongly inhibited by spermine, but not putrescine. There are also reports that among natural polyamines, spermine is the most effective in modulating voltage-activated, [41] [42] [43] Nmethyl-D-aspartate-mediated 44) and inositol trisphosphatestimulated 45) Ca 2+ channels, while putrescine has little or no effect. But these in vitro effects of spermine and spermidine observed at high concentrations (mM range) without depletion by specific inhibitors may be explained by their polybasic natures, resulting in their high affinities to negatively charged cellular structures such as biomembranes and nucleic acids and low-molecular-weight metabolites. With regard to the latter, Mernissi-Arifi et al. 46) reported the formation of stable complexes of spermine and spermidine with inositol trisphosphate. Moreover, there are reports that the cellular spermine level does not change appreciably under a variety of physiological conditions 1, 16, 17) in which the putrescine level is markedly elevated. Therefore, the relationship between the observed effects of high concentrations of spermine in vitro and their physiological regulatory functions in vivo must be considered with caution. 1) Recently, Khan et al. 47) reported that KCl depolarizationinduced serotonin release from fish brain synaptosomes is mediated by KCl-stimulated influx of Ca 2+ into the synaptosomes from the extracellular medium and that DFMOpretreatment resulted in decreases of both Ca 2+ influx and serotonin release which were restored by putrescine, the tissue content of which is higher than those of spermidine and spermine in various parts of fish brain. Shinki et al. 48) reported that in vitamin D-deficient chick small intestine, treatment with calcitriol resulted in marked elevation of the putrescine level, mainly due to back-conversion of spermidine, 17) and stimulation of Ca 2+ absorption that is thought to be accompanied by enhanced Ca 2+ passage across both mucous and serous membranes of the epithelial cells. Lowering of the putrescine level by inhibitors of polyamine oxidase and ornithine decarboxylase decreased Ca 2+ absorption. These and the present results support the idea that putrescine is a cofactor for the Ca 2+ current through second messenger-stimulated or voltage-gated Ca 2+ channels present in either the endoplasmic reticulum or plasma membrane in putrescine-rich cells.
The function of the putrescine-dependent increase in [Ca 2+ ] i is unknown. Possibly this multifunctional messenger participates in at least cell migration and morphological transformation of tumor cells and their secretion or exocytosis of factors that stimulate their invasiveness, because these cellular events are thought to be accompanied by rearrangement of the actin-based cytoskeleton regulated by actin-binding proteins that are modulated by changes in [Ca 2+ ] i . [49] [50] [51] For example, with regard to the relationship between polyamines and cell migration, McCormack et al. 52, 53) found that DFMO treatment reduced the migration of small intestinal crypt cells concomitantly with decreases in their actin stress fibers and lamellipodia due to redistribution of F-actin and tropomyosin from stress fibers to the actin cortex, and that their reduced migration was completely restored by exogenous polyamines, putrescine being the essential polyamine for their migration. Because the endothelial cell layer, basement membrane and extracellular matrix are barriers against tumor cell invasion, tumor cells produce and secrete factors that weaken or remove these barriers. These factors include an endothelial cell retraction factor 54) and a matrix metalloproteinase-2 whose transcription in human cancer cells is enhanced by receptor-operated Ca 2+ influx. 55) In summary, we have demonstrated a novel function of putrescine in Ca 2+ release from the ryanodine channel. The precise mechanism of this action of putrescine is unknown, but the findings that 1,3-diaminopropane and 1,5-diaminopentane had scarcely any effect and the demonstration of an early response (within 2 min, Figs. 2, 4 and 5) of [Ca 2+ ] i to putrescine imply that putrescine interacts with a specific site on the cyclic ADP-ribose binding receptor. 
